BioSpace News Archive

Tetra Bio-Pharma and Targeted Pharmaceuticals enter into an agreement to further its collaboration and co-development activities to advance Antiviral Central Nervous System Program

Gyroscope Therapeutics Limited, a clinical-stage gene therapy company focused on treating diseases of the eye, announced that it expects to consider additional capital raising options this year, which could include an initial public offering in the United States.

Labcorp, a leading global life sciences company, announced the appointment of Kathryn Wengel, current Executive Vice President and Chief Global Supply Chain Officer at Johnson & Johnson, as an independent member of Labcorp’s Board of Directors, effective immediately.

Acerus Pharmaceuticals Corporation (“Acerus” or the “Company”) (TSX: ASP; OTCQB: ASPCF) today announced that it has entered into an amended agreement related to its existing credit facility with SWK Funding LLC (“SWK”), a subsidiary of SWK Holdings Corporation (Nasdaq: SWKH).

Kronos Bio, Inc. (Nasdaq: KRON), a company dedicated to transforming the lives of those affected by cancer, today announced the appointment of Taiyin Yang, Ph.D., to the company’s board of directors.

Aridis Pharmaceuticals, Inc. (Nasdaq: ARDS), a biopharmaceutical company focused on the discovery and development of novel anti-infective therapies to treat life-threatening infections, today announced an interview with Vu Truong, Ph.D., Chief Executive Officer will air on The RedChip Money Report®

Sexton Biotechnologies, in partnership with Hitech Health and Med Institute, is working towards continued innovations in flexible automation

Maverick Health, a leader in cutting-edge, end-to-end diagnostic testing solutions that provide patients with actionable insights and access to their virtual physician network, today announces its partnership with Visby Medical to offer FDA authorized, instrument-free, rapid PCR testing to its organizational partners,

As more and more schools work to support in-person learning environments, communities across the country have turned to COVID-19 testing programs to monitor the virus. Even as teachers and guardians become eligible for and receive effective and safe vaccines, clinical vaccine trials for individuals under 16 are just beginning, and efforts to track and mitigate viral spread remain critical.

Akili Interactive (“Akili” or “Company”), today announced the publication of full data from a multi-site open-label study (STARS Adjunct) evaluating the impact of EndeavorRxTM (AKL-T01) on symptoms and functional impairments in children with attention- deficit/hyperactivity disorder (ADHD).